Back to search

Lyra Pharma Limited

13747076

active
Private Limited Company
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Current liabilities exceed current assets (-10)

Details

CANNON PLACE, LONDON, EC4N 6AF
Incorporated 16/11/2021

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Mr Craig Podolsky

director · Since 16/11/2021

COMPANY DIRECTOR

CANADIAN · UNITED STATES · Age 45

Ian Jacobson

director · Since 23/12/2021

COMPANY DIRECTOR

CANADIAN,BRITISH · CANADA · Age 66

Mr Graham Julian Fraser-Pye

director · Since 07/05/2022

COMPANY DIRECTOR

BRITISH · UNITED KINGDOM · Age 58

Also on 5 other boards

Persons with Significant Control

Mr Ian Jacobson

25–50% shares
25–50% votes

Canadian,British · Canada · Age 66

Cannon Place, 78 Cannon Street, London, EC4N 6AF

Notified 16/11/2021

CompanyRankvs 2046+ SIC 72110 peers
43

Financial strength71th percentile among SIC peers · 18/25
Employees22th percentile among SIC peers · 3/15
LiquidityCurrent ratio 0.38× · 2/20
Longevity5 years trading (max 15) · 5/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength18/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees3/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity5/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2024

Net Worth

£30k

Balance sheet strength

Cash

£173k

Cash in the bank

Net Current Assets

-£315k

Working capital

Current Assets

£189k

Current Liabilities

£504k

Debtors

£16k

0avg. employees
Prepared with CCH Software

EstimatesDerived

YearCurrent RatioImplied Profit
20240.38+£6k
20230.78+£0
20221.48

Derived from filed accounts. Not audited figures.